Weight-loss medications
Foundayo (orforglipron) is a daily GLP-1 pill for weight loss with no fasting requirements. FDA-approved April 2026. Average weight loss 11.2% at 72 weeks.
Current Health
New research finds GLP-1 users are judged more harshly than dieters, and sometimes more than people who haven't lost weight. Here's what the study shows.
Weight-loss medications
Retatrutide produced 28.7% weight loss in trials vs Wegovy 7.2 mg's 20.7%. Retatrutide isn't UK-approved yet; Wegovy is the current option.
Weight-loss medications
Retatrutide's main side effects in trials: nausea (43%), heart rate increase of ~6.7 bpm, and dysesthesia (20.9%) at the 12 mg dose. Not yet UK-approved.
Weight-loss medications
In trials, retatrutide reached 28.7% weight loss vs Mounjaro's 22.5%. Retatrutide isn't UK-approved yet, so Mounjaro is the current option.
Dessert
A vegetarian dessert with almonds, coconut flour, and flaxseed. Ready in 1 hr 15 mins. Serves 8. Developed by Second Nature dietitians.
Vegetarian/vegan
A vegan recipe with tofu, red chilli, and limes. Ready in 30 minutes. Serves 2. Developed by Second Nature dietitians.
Vegetarian/vegan
A vegetarian Italian recipe with vine cherry tomatoes, red peppers, and ricotta. Ready in 40 mins. Serves 4. Developed by Second Nature dietitians.
Breakfast and eggs
A vegetarian breakfast with almonds, walnut halves, and pecans. Ready in 45 minutes. Developed by Second Nature dietitians.
Dessert
A vegetarian dessert with dates, raisins, and brandy. Ready in 1 hr 30 mins. Serves 4. Developed by Second Nature dietitians.
As seen on
As seen on